Analyst initiated coverage of Relay Therapeutics and mentioned a promising late-stage breast cancer trial at Canino.
1 report, 1 independent
Updated Sep 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst initiated coverage of Relay Therapeutics and mentioned a promising late-stage breast cancer trial at Canino.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Relay Therapeutics
company in Cambridge, United States
-
Canino
primary school in Canino, Viterbo, Lazio, Italy
Nothing else this week.
Coverage
Newest first; wire copies grouped- Motley FoolWhy Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week An analyst initiated coverage of the biotech. Not only does he consider it a buy, he's also designated it as one of his firm's top pi